UnitedHealth Group Incorporated $UNH Shares Sold by Kozak & Associates Inc.

Key Points

• Kozak & Associates Inc. reduced its position in UnitedHealth Group by 39.9% in Q2, holding 1,183 shares valued at $358,000.
• Several large investors, including Bayforest Capital Ltd and Clal Insurance Enterprises Holdings Ltd, significantly increased their stakes in UnitedHealth Group during the first quarter.
• UnitedHealth Group reported earnings of $4.08 per share, missing estimates, while also declaring a quarterly dividend of $2.21 per share, reflecting a 2.6% yield.

Kozak & Associates Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,183 shares of the healthcare conglomerate's stock after selling 786 shares during the quarter. Kozak & Associates Inc.'s holdings in UnitedHealth Group were worth $358,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the period. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $42,000. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group in the 1st quarter worth $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $44,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a research note on Friday, September 5th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Piper Sandler decreased their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $1.90 during mid-day trading on Friday, reaching $336.72. The stock had a trading volume of 13,528,738 shares, compared to its average volume of 13,748,202. The business's fifty day moving average is $295.67 and its 200-day moving average is $365.19. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $304.96 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 2.19 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.